Cri-du-chat Syndrome Treatment Market Expected to Reach $1.9 Million by 2031—Allied Market Research

According to a new report published by Allied Market Research, titled, “Cri-du-chat Syndrome Treatment Market," The cri-du-chat syndrome treatment market was valued at $1.3 million in 2021, and is estimated to reach $1.9 million by 2031, growing at a CAGR of 3.7% from 2022 to 2031.

When a portion of chromosome number 5 is missing, a series of symptoms known as "cri du chat syndrome" develop. The name of the syndrome is derived from the baby's high-pitched, feline-like cry. The majority of occurrences are thought to happen when the egg or sperm are developing. There are a few instances where a parent transmits their child a different, rearranged form of the chromosome.
Cri du Chat syndrome is typically not inherited within families and this deletion takes place extremely early in an embryo's development. The clinical examination, the patient's symptoms, and the results of genetic testing are used to make the diagnosis. 

There is no pharmacological treatment for this disease. Thus, there is significant rise in awareness about physiotherapy for the treatment of the cri-du-chat syndrome is the major factor driving the market growth. In addition, increase in healthcare expenditure is the upcoming cri-du-chat syndrome treatment market trends in emerging economies also propels the market growth.

However high cost associated with treatment of physiotherapy is expected to hinder the market growth. Conversely, rising purchasing power, emerging economies in Asia-Pacific and LAMEA have one of the highest growth potentials for the cri-du-chat syndrome treatment market.

The cri-du-chat syndrome treatment market analysis is segmented by treatment, end user and region. On the basis of treatment, the market is segmented into physiotherapy, occupation therapy and speech therapy. The physiotherapy segment dominated the cri-du-chat syndrome treatment market size in 2021, and also expected to witness highest CAGR during the forecast period, owing to rise in awareness and advantages about physiotherapy. 

On the basis of end user, the market is divided into hospitals & specialty clinics and others. The hospitals & specialty clinics segment dominated the cri-du-chat syndrome treatment market size  in 2021, owing to hospitals & specialized centers provides high specialized treatment for such patients. The others segment is expected to witness highest CAGR during the forecast period owing to rise in demand for the home care private services and increase in the number of medical institutes that provide such treatments.

North America accounted for a majority of the global cri-du-chat syndrome treatment market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to technological advancements in physiotherapy techniques, rise in awareness about occupational & speech treatment for cri-du-chat syndrome, presence of key and robust hospital infrastructure in the region. However, Asia-Pacific is anticipated to witness notable growth in the cri-du-chat syndrome treatment market forecast, owing to rise in cri-du-chat syndrome, development of healthcare infrastructure and increase in investments projects in the region.

Key findings of the study
•    On the basis of treatment, the physiotherapy segment was the highest contributor to the cri-du-chat syndrome treatment market share in 2021.
•    On the basis of end user, the hospitals and specialty clinics segment was highest contributor in 2021, and is expected to continue this trend during the forecast period in the cri-du-chat syndrome treatment industry.
•    Region wise, North America garnered the largest revenue share in cri-du-chat syndrome treatment industry in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.